High-throughput screening to engineer optimal T cell therapies: current knowledge and future prospects
{{output}}
Adoptive T cell therapy (ACT) is a potent strategy in cancer immunotherapy, but its clinical efficacy is often limited by primary resistance. To overcome this challenge, high-throughput screening technologies have emerged as essential tools for optimizing ACT.... ...
